Preventing and Treating Malnutrition in Cancer Patients
Malnutrition may affect 30% to 85% of cancer patients, and it may account for 10% to 20% of deaths in these patients.
Malnutrition may affect 30% to 85% of cancer patients, and it may account for 10% to 20% of deaths in these patients.
Experts describe how ChatGPT and other AI technologies will transform health care and research.
Medicaid expansion is associated with increased use of palliative care for patients with advanced cancer, a study suggests.
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients.
Overweight BMI is associated with favorable outcomes in patients with nonmetastatic head and neck cancer undergoing chemoradiotherapy.
The main cause of the cancer drug shortage, experts agree, is the underlying weakness of the generic drug industry.
Research suggests a high prevalence of uncontrolled cardiovascular risk factors among patients with head and neck cancers.
Oncology leaders testified before a House subcommittee about how drug shortages are hindering cancer care in the US and threatening the lives of patients.
Gemcitabine plus cisplatin provides benefits over 5-fluorouracil plus cisplatin as adjuvant treatment for nasopharyngeal carcinoma, phase 3 data suggest.
Adding nimorazole to radiotherapy does not improve outcomes in patients with locally advanced head and neck cancer who have tumor hypoxia, phase 3 data suggest.